Fresenius Medical Care (FMS) vs Mangoceuticals (MGRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Fresenius Medical Care is the larger company by market cap ($11.11 billion vs $9.3 million), about 1191.6 times the size. Fresenius Medical Care pays a dividend yielding 7.14%, while Mangoceuticals does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | FMS | MGRX |
|---|---|---|
| Share price | $20.88 | $0.4324 |
| Market cap | $11.11B | $9.33M |
| 1-day change | +0.92% | -2.55% |
| YTD return | -13.14% | — |
| 1-year return | -22.86% | — |
| 5-year return | -41.65% | — |
| P/E ratio (TTM) | 10.76 | — |
| Forward P/E | 6.95 | — |
| EPS (TTM) | $1.94 | $-1.02 |
| Dividend yield | 7.14% | 0.00% |
| Annual dividend | $1.49 | $0.00 |
| Revenue (latest FY) | $4.97B | — |
| Revenue growth (YoY) | -63.98% | — |
| Net income (latest FY) | $1.11B | — |
| Gross margin | 95.33% | — |
| Operating margin | 45.39% | — |
| Net margin | 22.33% | — |
| 52-week high | $27.64 | $2.75 |
| 52-week low | $20.02 | $0.162 |
| Distance from 52-week high | -24.46% | -84.28% |
| Analyst consensus | hold | — |
| Avg. price target upside | +12.21% | — |
| Average volume | 740.08K | 12.83M |
| Shares outstanding | 532.22M | 21.57M |
| Employees | 107,226 | — |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fresenius Medical Care is about 1191.6 times larger than Mangoceuticals by market value ($11.11B vs $9.33M).
- Fresenius Medical Care offers a meaningfully higher dividend yield (7.14% vs 0.00%).
About Fresenius Medical Care
FMS stock →Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Health Care · Misc Health and Biotechnology Services · 107,226 employees
FMS vs MGRX FAQ
Which is bigger, Fresenius Medical Care or Mangoceuticals?
Fresenius Medical Care (FMS) is larger, with a market capitalization of $11.11B compared with $9.33M for Mangoceuticals (MGRX).
Which pays a higher dividend, Fresenius Medical Care or Mangoceuticals?
Fresenius Medical Care pays a dividend yielding 7.14%, while Mangoceuticals does not currently pay a regular dividend.
Are Fresenius Medical Care and Mangoceuticals in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.